News

Global Research
globalresearch. ca > cancer-patients-taking-ivermectin-mebendazole-reported-no-evidence-disease-tumor-regression > 5922629

84. 4% of Cancer Patients Taking Ivermectin + Mebendazole Reported No Evidence of Disease, Tumor Regression, or Cancer Stabilization After 6 Months

1+ mon, 1+ week ago  (302+ words) I joined Steve Gruber on Real America's Voice to break down what is now the largest real-world human analysis of ivermectin and mebendazole in cancer patients. 84. 4% of the cancer patients taking ivermectin + mebendazole reported no evidence of disease, tumor regression,…...

Symbols: lse:azn